Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its... see more

TSXV:SQD.H - Post Discussion

SQI Diagnostics Inc > Barron's has a $6.00 target on SQI Diagnostics
View:
Comment by pirateinvestor on Aug 26, 2022 11:38am
Maybe it is a typo.. should read .06c On our way with new low .10c PI
Comment by Surfnslide on Aug 26, 2022 6:06pm
Extremely cheap. Load up! SS
Comment by FactFinder1994 on Aug 29, 2022 9:27am
Yes Surf, it is extremely cheap.   What do you believe are some of the potential top catalysts that will be in play shortly?  
Comment by FactFinder1994 on Sep 02, 2022 4:08pm
Yes SURF, it is extremely cheap.   What do you believe are some of the potential top catalysts that will be in play shortly?  
Comment by FactFinder1994 on Oct 06, 2022 9:22am
Agreed Surfnslide.  This is extremely cheap.   RALI-Dx was submitted to HC in November of 2021, so you have believe it will see approval before year anniversary.   While I believe there are many other positives, I'd be interested in hearing your thoughts as well.   Thank you, 
Comment by 25Stone7859 on Oct 06, 2022 5:28pm
The $6 target is absurd. There is no research. While SQI has a big suite of propretary I/P with seemingly huge potential, investors are not concinced SQI will get to the finish line. Think about: 1. RALI dx  ? 2. Antibody test ? 3. TOR dx Lung ? 4. OwlStone ? 5. McMaster ? 6. PBI acquisition sales down 80% Q3 vs Q2 ? and the big one: 6. Financing ? SQI seems to be stalled here at $0.09 ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities